Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.46, $0.09 better than the analyst estimate of $0.37. Revenue for the quarter came in at $470.3 million versus the consensus estimate of $464.49 million.

GUIDANCE:

Bruker sees FY2017 EPS of $1.05-$1.09, versus the consensus of $1.10.

• For FY 2017, the Company expects reported revenue growth of 1.5% to 2.5%, which includes organic revenue growth of 1% to 2%, and growth from acquisitions of 3.5% to 4%. Changes in foreign currency rates are expected to have a negative impact on reported revenues of 3% to 3.5%.
• Starting with our non-GAAP operating margin of 14.8% in 2016, and including the effects of our recent acquisitions, Bruker expects to increase its FY 2017 non-GAAP operating margin by 40 bps to 70 bps year-over-year. This includes approximately 40 bps headwind in FY 2017 from our recent strategic acquisitions.

For earnings history and earnings-related data on Bruker (BRKR) click here.